发明授权
US6140100A Cell-targeting molecule comprising a mutant human carboxypeptidase A
失效
包含突变型人羧肽酶A的细胞靶向分子
- 专利标题： Cell-targeting molecule comprising a mutant human carboxypeptidase A
- 专利标题（中）： 包含突变型人羧肽酶A的细胞靶向分子
-
申请号： US640906申请日： 1996-05-09
-
公开(公告)号： US6140100A公开(公告)日： 2000-10-31
- 发明人: Gary Keith Smith , Todd Andrew Blumenkopf , Michael Cory
- 申请人： Gary Keith Smith , Todd Andrew Blumenkopf , Michael Cory
- 申请人地址： NC Research Triangle Park
- 专利权人： Glaxo Wellcome Inc.
- 当前专利权人： Glaxo Wellcome Inc.
- 当前专利权人地址： NC Research Triangle Park
- 优先权： GBX9323429 19931112
- 主分类号： C12N15/09
- IPC分类号： C12N15/09 ; A61K38/00 ; A61K47/48 ; C12N1/19 ; C12N9/48 ; C12N9/64 ; C12N9/96 ; C12N15/57 ; C12R1/865 ; C12N15/62 ; C12N15/79
摘要：
Conjugates of a cell targetting molecule and a mutant human carboxypeptidase A enzyme are provided. Suitable targetting molecules include antibodies, hormones, ligands, cytokines, antigens, oligonucleotides and peptidomimetics. Enzymes comprising a mutant human carboxypeptidase A enzyme are also provided.
公开/授权文献
- US5098614A Adjustable bubble bend 公开/授权日：1992-03-24
信息查询
IPC分类:
